Compete against your peers with our rheumatoid arthritis clinical quiz.
Ankylosing Spondylitis and Axial Spondyloarthritis Treatment Recommendations: A Clinical Practice Assessment
Compete against your peers with our ankylosing spondylitis/nonradiographic axial spondyloarthritis clinical quiz.
The effects of alcohol on the body's systems are examined here, with both damaging and potentially protective effects being explored.
While studies on the effect of the gut microbiome on spondyloarthritis are limited, new research and technology are poised to expand future microbiome-directed arthritis treatments.
Patients with rheumatoid arthritis have an increased risk of developing cardiovascular disease (CVD) and CVD-related mortality compared with the general population. Despite the growing recognition of CVD as a common complication of RA, many rheumatologists do not aggressively manage CV risk in patients with rheumatic disease.
Lorraine Fitzpatrick, MD, discusses updated results from the ACTIVE phase 3 clinical trial.
Dinesh Khanna, MD, MSc, discusses results of the open-label portion of a trial evaluating the safety and efficacy of placebo-treated patients with systemic sclerosis who were switched to received open-label tocilizumab.
John H. Stone, MD, MPH, discusses results from a phase 3, double-blind, randomized, controlled trial evaluating the efficacy of tocilizumab for the treatment of giant cell arteritis.
Gerd Burmester, MD,discusses results from the SARIL-RA-MONARCH trial.
Sarah Taber, MD, briefly reviews her ongoing research on genetic drivers of localized scleroderma in pediatric patients.
Kenneth Saag, MD, discusses new pooled safety data for lesinurad for the treatment of gout.
Researchers suggest that relapsing MPA and GPA and increased BMI were associated with increased glucocorticoid exposure following induction of remission.
Eric L. Matteson, MD, MPH, sat down with Rheumatology Advisor to discuss the morbidity associated with interstitial lung disease in RA.
Nancy E. Lane, MD, professor of medicine, at the University of California at Davis School of Medicine, discusses results from the phase 3 ACTIVE trial.
Patient-reported outcomes have become a very important way to gain insight into outcomes of disease.
Mary K. Crow, MD, discusses upcoming presentations at the ACR annual conference to be held November 11 - 16, in Washington, DC.
Validation of a patient-report outcome instrument as an effective independent tool for measuring disease activity and treatment response may one day allow decreased reliance on expensive or time-consuming assessments, such as magnetic resonance imaging or joint counts.
Pregnancy is a major consideration in patients with spondyloarthritis, and family planning discussions should be undertaken in patients of reproductive age as early as possible to ensure optimal outcomes when starting or expanding a family is desired.
Rheumatology Advisor Articles
- Rheumatoid Arthritis Increases Mortality Risk in Staphylococcus aureus Infections
- First Clinical Practice Guidelines for Sjögren's Syndrome Developed
- Antibiotic Resistance Problem Brought Before Congress
- FDA Delays Approval of JAK Inhibitor Baricitinib
- How Effective is RF Denervation for Symptomatic Knee OA?
- Allopurinol Use In Concomitant Gout and Diabetes Lowers Cardiovascular Event Risk
- Measuring Disease Activity in Psoriatic Arthritis
- JAK/STAT Inhibitors: A New Treatment Target for Rheumatoid Arthritis
- Biosimilar Confidence: Physician-Patient Communication Sets the Tone
- VA and DoD Practice Guideline Update: Opioids for Chronic Pain
- Leg Positioning During Lumbar DXA Does Not Impact Trabecular Bone Scores
- Should Trabecular Bone Score Be Used to Predict Fragility Fracture Risk in T1D?
- DXA for Pediatric Bone Age Assessment Yields Similar Results vs Traditional Radiography
- Remote Osteoporosis Specialist Mentoring Program Improves Physician Self-Confidence
- Increased Costs Associated With Specialists Providing Primary Care